• 四川大學(xué)華西醫(yī)院腫瘤中心,四川成都 610041;

引用本文： 李俊,劉繼彥. 結(jié)腸腺癌合并原發(fā)性肝癌骨轉(zhuǎn)移1例. 華西醫(yī)學(xué), 2009, 24(4): 1046-1046. doi: 復(fù)制

1. [carcinoma patients: preliminary results of a phase study[J1]楊永紅,王安群,許榮雙.原發(fā)性肝細胞性肝癌與胃腺癌并存一例[J].四川腫瘤防治,1997,10:4..
2. 張樹榮,田學(xué)明,歐秋生,等.直腸癌并原發(fā)性肝癌2例報道[J].中國腫瘤臨床與康復(fù),2001,8:46..
3. 翠鋒,李云峰.升結(jié)腸癌合并原發(fā)性小肝癌同期治療1例[J].世界華人消化雜志,2007,15(28):3054-3055..
4. 李林,佘志廉,柳碩巖,等.上消化道多原發(fā)癌的診治分析[J].中國胸心血管外科雜志2001,8(2):134-135..
5. 宋會安,孔迪生.多原發(fā)性結(jié)直腸癌/例治療體會[J].中國現(xiàn)代醫(yī)學(xué)雜志,2001,10(6):64..
6. 范黎,于釗,任軍,等.4例多原發(fā)癌的病種分布和預(yù)后分析[J].第四軍醫(yī)大學(xué)學(xué)報,2002,23(1):95-96..
7. MELIA W M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etoposide (VP-16) with adriamycin[J]. Cancer,1983,51:206..
8. SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1):s143..
9. PORTA C, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricalcium are active to treat unresectable hepatocellular ]. Oncology,1995,52:487.
10. KHOO K S, AU E, KOO W H, et al. PhaseⅡ study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J]. Pro Am Soc Clin Oncol,1996,15:226..
  1. 1. [carcinoma patients: preliminary results of a phase study[J1]楊永紅,王安群,許榮雙.原發(fā)性肝細胞性肝癌與胃腺癌并存一例[J].四川腫瘤防治,1997,10:4..
  2. 2. 張樹榮,田學(xué)明,歐秋生,等.直腸癌并原發(fā)性肝癌2例報道[J].中國腫瘤臨床與康復(fù),2001,8:46..
  3. 3. 翠鋒,李云峰.升結(jié)腸癌合并原發(fā)性小肝癌同期治療1例[J].世界華人消化雜志,2007,15(28):3054-3055..
  4. 4. 李林,佘志廉,柳碩巖,等.上消化道多原發(fā)癌的診治分析[J].中國胸心血管外科雜志2001,8(2):134-135..
  5. 5. 宋會安,孔迪生.多原發(fā)性結(jié)直腸癌/例治療體會[J].中國現(xiàn)代醫(yī)學(xué)雜志,2001,10(6):64..
  6. 6. 范黎,于釗,任軍,等.4例多原發(fā)癌的病種分布和預(yù)后分析[J].第四軍醫(yī)大學(xué)學(xué)報,2002,23(1):95-96..
  7. 7. MELIA W M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etoposide (VP-16) with adriamycin[J]. Cancer,1983,51:206..
  8. 8. SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1):s143..
  9. 9. PORTA C, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricalcium are active to treat unresectable hepatocellular ]. Oncology,1995,52:487.
  10. 10. KHOO K S, AU E, KOO W H, et al. PhaseⅡ study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J]. Pro Am Soc Clin Oncol,1996,15:226..